Overall rank by patents
#28,711
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 3 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
The verdict
Etiometry holds 9 US patents across 3 technology areas, rank #28,711 of 50,000 tracked assignees.
Etiometry Inc. has been granted 9 US utility patents between 2018 and 2025, placing Etiometry Inc. at rank #28,711 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.9 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, Etiometry Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Etiometry sits between Epona Llc (9 patents, rank #28,707) and Ewig Industries Macao Commercial Offshore Limited (9 patents, rank #28,715) - the closest US assignees by grant volume. The composite Innovation Score of 43.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 1 in the 2015–2019 window, a +700% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Etiometry Inc.'s 14.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Etiometry Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Epona LLC
9 patents
Estis Compression, LLC
9 patents
Estwing Manufacturing Company, Inc.
9 patents
Etihad Airways
9 patents
Eucure (Beijing) Biopharma Co., Ltd
9 patents
Eulitha AG
9 patents
EverBlock Systems LLC
9 patents
Ewig Industries Macao Commercial Offshore Limited
9 patents
Etiometry Inc.
9 patents
What this shows Etiometry holds 9 patents at rank #28,711, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,711 in granted patent volume.
Other assignees with the most granted patents in Etiometry's primary technology class.
Etiometry's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 11.1% |
| 2020 | 1 | 11.1% |
| 2022 | 1 | 11.1% |
| 2023 | 3 | 33.3% |
| 2024 | 1 | 11.1% |
| 2025 | 2 | 22.2% |
Top 3 of 3 technology areas
Overall rank by patents
#28,711
Across all tracked assignees
43.0 out of 100
How to use this portfolio
Etiometry's 9 grants land it in the top 29% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.